Actuate Therapeutics, Inc. Common stock (ACTU)
Healthcare
Biotechnology
1.10 $
-5.1%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns Actuate Therapeutics, Inc. Common stock (ACTU)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 35.8% of the shares are freely tradable; institutional investors hold 58.2%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
58.2%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
15.4%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
35.8%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
8.7%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
24Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| BIOS CAPITAL MANAGEMENT, LP | 42.00 | 10,049,996 | +0.0 | 03/31/2026 |
| Voss Capital LLC | 7.21 | 1,725,000 | +32.7 | 03/31/2026 |
| Vanguard Group Inc | 2.21 | 529,111 | +67.4 | 12/31/2025 |
| BlackRock Inc | 1.79 | 427,153 | -1.1 | 03/31/2026 |
| Vanguard Capital Management, LLC | 1.67 | 400,529 | +0.0 | 03/31/2026 |
| Geode Capital Management, LLC | 0.95 | 228,331 | +9.9 | 03/31/2026 |
| Connective Capital Management LLC | 0.47 | 113,266 | +0.0 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 1.20 | 287,385 | +0.0 | 04/30/2026 |
| iShares Russell 2000 ETF | 0.76 | 180,771 | +0.9 | 05/29/2026 |
| Vanguard Institutional Extnd Mkt Idx Tr | 0.44 | 106,405 | +0.0 | 04/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.